SOLICITATION NOTICE
66 -- Microfluidics Microfluidizer Processor
- Notice Date
- 8/13/2012
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-120176-LG
- Archive Date
- 9/12/2012
- Point of Contact
- Laura Glockner, Phone: 3014968607
- E-Mail Address
-
laura.glockner@nih.gov
(laura.glockner@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Boulevard, EPS Suite 600, Room 6070, Rockville, MD 20852, UNITED STATES. Description The National Cancer Institute (NCI), Cancer Center Research (CCR), Laboratory of Biochemistry and Molecular Biology (LBMB) plans to procure on a sole source basis the brand name Microfluidizer Processor M-110P from Microfluidics Corporation, 30 Ossipee Road, Newton, MA 02464-9101. This acquisition will be processed in accordance with simplified acquisition procedures in FAR Part 13.106 (b)(1). The North American Industry Classification System code is 334516 and the business size standard is 500 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Delivery Date: 45 days from date of award. It has been determined that there is no opportunity to acquire green products or services under this contract. The Microfluidics Processor utilizes monolithic ultra-pure alumina ceramic (standard) or monolithic polycrystalline diamond (optional) in the energy zone of the interaction chamber for minimum wear and no product contamination. Also, the processor provides interrupted constant press through fixed micro-channels in the Interaction Chamber for consistent shear input and sample repeatability. The Microfludics unit is the only known product that can supply these features. The following salient characteristics apply to the Microfluidizer Processor M-110P: • obtains a minimum shear rate of 6.0 million sec-1 @ 1379 bar (20,000 psi) operating pressure for maximum processing efficiency • obtains a nominal flow rate of 135 ml/min on water at 1379 bar (20,000 psi) for rapid product processing • processes product continuously at maximum operating pressure using electric power as the only utility from 220V/12 amp/50 Hz plug-in wall connection • has a 10 foot long coiled single pass heat exchanger for maximum heat removal and bioactivity in processed sample • retains product in the energy zone for 1 millisecond for minimal heat absorption resulting in maximum bioactivity or product stability • utilizes monolithic ultra-pure alumina ceramic (standard) or monolithic polycrystalline diamond (optional) in the energy zone of the Interaction Chamber for minimum wear and no product contamination. • provides interrupted constant pressure through fixed micro-channels in the Interaction Chamber for consistent shear input and unmatched sample repeatability • automatically stops processing product without exceeding set operating pressure upon accidental downstream pipeline closure for operator safety • maintains internal flow rates of 15 ft/sec in high pressure piping for reliable cleaning without machine disassembly (CIP) • capable of chemical sterilization on all product contact surfaces for absolute sterility control to insure operator safety and sample integrity • System is be CE compliant Microfluidics' product is the only known product that will provide enzyme or protein activity yield up to double the results of other methods which is attributed to high disruption rate (due to efficient energy input) and minimum heating (due to the high efficacy standard in-line heat exchanger). This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisition on or before 11:00 AM EST on August 27, 2012. No electronic capability statements will be accepted (i.e. email or fax) an original and one copy must be sent to the NCI Office of Acquisition to the address stated above. All questions must be in writing and can be faxed (301) 402-4513 or emailed to Laura Glockner, Contract Specialist at laura.glockner@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) through SAM.gov. No collect calls will be accepted. Please reference solicitation number NCI-120176-LG on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-120176-LG/listing.html)
- Record
- SN02836859-W 20120815/120813235936-3616ef9df5aa4eb3532ecac362654b5d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |